Global Molecular Diagnostics Market Overview 2023-2028

IMARC Group, a leading market research company, has recently releases report titled Molecular diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. The study provides a detailed analysis of the industry, including the global Molecular diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Molecular diagnostics is a cutting-edge field of medical testing that focuses on detecting and analyzing specific genetic or molecular markers to diagnose diseases, assess disease risk, and personalize treatments. It delves into the molecular and genetic makeup of an individual to provide precise and targeted information. It involves analyzing nucleic acids, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), and proteins to identify genetic mutations, gene expressions, or infectious agents that can be indicative of certain diseases or conditions. It is instrumental in identifying and characterizing contagious agents, including bacteria, viruses, and parasites.

Global Molecular Diagnostics Market Trends and Drivers:

The increasing adoption of molecular diagnostics to enable personalized and targeted treatment approaches based on the genetic makeup of an individual represents one of the primary factors strengthening themarket growtharound the world. Moreover, the rising use of molecular diagnostics to detect diseases at their earliest stages, which improves patient outcomes and reduces healthcare costs, is favoring the growth of the market. In addition, the surging prevalence of chronic diseases, such as cancer, cardiovascular diseases, and genetic disorders, is catalyzing the demand for molecular diagnostics for disease monitoring and management. Apart from this, the growing adoption of molecular diagnostics at the point-of-care facilitates rapid and real-time diagnosis, is influencing the market positively.

Global Molecular Diagnostics Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.

The report segmented the market on the basis of region, product, technology, application and end users.

Breakup by Product:

• Reagents and Kits
• Instruments
• Software and Services

Breakup by Technology:

• Polymerase Chain Reactions (PCR)
• Hybridization
• DNA Sequencing
• Microarray
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

Breakup by Application:

• Infectious Diseases Diagnostics
• Oncology
• Genetic Testing
• Blood Screening
• Others

Breakup by End Users:

• Hospitals
• Laboratories
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porters Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email:Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800